The Consistency Project cover image

on the Weight Loss Drug That...Works?

The Consistency Project

00:00

The Effects of Adjunk on Weight Loss

There is another phase three clinical trial. This one's the Rubino paper and the show notes. Those who continue to take semilutide, they lost an additional 7.9% of their body weight. While those who switched to placebo regained an average of 6.9%. And so that's, I think some of the strongest evidence to suggest that people will have to stay on this so long as they want to maintain the weight loss.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app